IL7 and precursor B-cell acute lymphoblastic leukemia: Notably, even though heavily pretreated and TN-deficient, our cohort of B-ALL patients successfully responded to the optimized manufacturing procedure, supporting the notion that proper activation in the presence of IL-7 and IL-15 can rescue initial T cell defects (35).